RT Journal Article
SR Electronic
T1 The impact of testing and infection prevention and control strategies on within-hospital transmission dynamics of COVID-19 in English hospitals
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.12.20095562
DO 10.1101/2020.05.12.20095562
A1 Stephanie Evans
A1 Emily Agnew
A1 Emilia Vynnycky
A1 Julie Robotham
YR 2020
UL http://medrxiv.org/content/early/2020/05/20/2020.05.12.20095562.abstract
AB Nosocomial transmission of SARS-CoV-2 is a key concern and evaluating the effect of testing and infection prevention control strategies is essential for guiding policy in this area. Using a within-hospital SEIR transition model of SARS-CoV-2 in a typical UK hospital, we predict that approximately 20% of infections in inpatients, and 89% of infections in HCWs were due to nosocomial transmission. Placing suspected COVID-19 patients in single rooms or bays has the potential to reduce hospital-acquired infections in patients by up to 80%. Periodic testing of HCWs has a smaller effect on the patient-burden of COVID-19 but would considerably reduce infection in HCWs by as much as 64% and result in only a small proportion of staff absences (approximately 1% per day). This is considerably fewer than currently observed due to suspected COVID-19 and self-isolation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding received.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesModel code and parameters included in supplement, calibration data privately held.